A unique CD8(+) T lymphocyte signature in pediatric type 1 diabetes

作者：Hamel Yamina; Mauvais Francois Xavier; Hang Phuong Pham; Kratzer Roland; Marchi Christophe; Barilleau Emilie; Waeckel Enee Emmanuelle; Arnoux Jean Baptiste; Hartemann Agnes; Cordier Corinne; Megret Jerome; Rocha Benedita; de Lonlay Pascale; Beltrand Jacques; Six Adrien; Robert Jean Jacques; van Endert Peter

来源：Journal of Autoimmunity, 2016, 73: 54-63.

DOI：10.1016/j.jaut.2016.06.003

• CD8(+) T lymphocyte
• Gene expression profile
• Protein expression signature
• Single cell PCR
• Type 1 diabetes

Human type 1 diabetes results from a destructive auto-reactive immune response in which CD8(+) T lymphocytes play a critical role. Given the intense ongoing efforts to develop immune intervention to prevent and/or cure the disease, biomarkers suitable for prediction of disease risk and progress, as well as for monitoring of immunotherapy are required. We undertook separate multi-parameter analyses of single naive and activated/memory CD8(+) T lymphocytes from pediatric and adult patients, with the objective of identifying cellular profiles associated with onset of type 1 diabetes. We observe global perturbations in gene and protein expression and in the abundance of T cell populations characterizing pediatric but not adult patients, relative to age-matched healthy individuals. Pediatric diabetes is associated with a unique population of CD8(+) T lymphocytes co-expressing effector (perforin, granzyme B) and regulatory (transforming growth factor beta, interleukin-10 receptor) molecules. This population persists after metabolic normalization and is especially abundant in children with high titers of auto antibodies to glutamic acid decarboxylase and with elevated HbA1c values. These findings highlight striking differences between pediatric and adult type 1 diabetes, indicate prolonged large-scale perturbations in the CD8(+) T cell compartment in the former, and suggest that CD8(+)CD45RA(-) T cells co-expressing effector and regulatory factors are of interest as biomarlcers in pediatric type 1 diabetes.

• 出版日期2016-9